A potential strategy for treating diabetes uses stem cells from the human stomach to create cells that release insulin in response to rising blood sugar levels.
Several studies have found a rise in type 1 diabetes during the COVID-19 pandemic. However, none of the research distinguishes between children infected with SARS-CoV-2 and those who are not. Researchers can now acquire fresh insights since the KVB data set contains information on whether ch
Getting a host immune system to accept the presence of implanted insulin-secreting cells could change the lives of the more than 700 million people who have Type 1 diabetes worldwide.
A little more than a century has gone since the discovery of insulin, and since then hormone's therapeutic abilities have grown and refined. Insulin is a critical treatment for type 1 diabetes and, in many cases, type 2 diabetes. According to the American Diabetes Association, 8.4 million Am
Two distinct subtypes of insulin-producing beta cells, or ss cells, have been discovered by a team of researchers led by scientists from the Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics. Each of these ss cell subtypes possesses critical traits that may be use
According to a new study, an artificial pancreas created at the University of Virginia Center for Diabetes Technologies improves blood sugar management in children aged 2 to 6 with type 1 diabetes.
According to researchers at Wake Forest University School of Medicine, rates of Type 1 and Type 2 diabetes continue to increase in children and young adults. Non-Hispanic Black and Hispanic children and young adults also had higher incidence rates of diabetes.
person with Type 1 diabetes has a smaller pancreas than someone without the disease. This is unexpected because insulin-producing beta cells make up a very minor portion of the pancreas and their loss in Type 1 diabetes would not be anticipated to result in a reduction in pancreas size.
New findings from researchers at Wake Forest University School of Medicine confirm that the rates of Type 1 and Type 2 diabetes continue to increase in children and young adults. Non-Hispanic Black and Hispanic children and young adults also had higher incidence rates of diabetes.
Approximately half of the people with type 1 or type 2 diabetes experience peripheral neuropathy -- weakness, numbness, and pain, primarily in the hands and feet. The condition occurs when high levels of sugar circulating in the blood damage peripheral nerves. Now, working with mice, Salk In
Researchers from the Regenstrief Institute showed that continuous glucose monitors and other wearable devices present wearability and use issues for patients and their carers when used by older persons with Type 1 or Type 2 diabetes to test and control low blood sugar.
An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce